Diseases & Disorders
(G43)
990 on File
INTERNATIONAL EOSINOPHIL SOCIETY INC
Financial strength (30%)
62/100
Reliability (20%)
50/100
Effectiveness (25%)
58/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$167K
Total Revenue
$137K
Total Expenses
$710K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
60.3%
Fundraising Efficiency
N/A
Operating Reserve
62.22x
Liability-to-Asset
2.2%
Revenue Diversification
78.6%
Compared with Peers
FY 2024
Compared with 1,541 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
60.3% | 83.1% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
36.5% | 10.9% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.2% | 0.3% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
62.2 mo | 12.0 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.2% | 0.7% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
78.6% | 93.9% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-68.8% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-53.3% | 9.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
17.9% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $167K | $137K | $710K | 60.3% | 0 |
| 2023 | $535K | $293K | $680K | 82.3% | 0 |
| 2022 | $168K | $46K | $439K | 2.7% | 0 |
| 2021 | $119K | $38K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.